Rapid Analysis of Outcomes Using the Systemic Anti-Cancer Therapy (SACT) Dataset

R. Pathak*, M. Wallington, C. Saunders, M. Braun, S. Mullamitha, G. Wilson, J. Hasan, D. Dodwell, M. Bomb, M. Saunders

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

We audited the accuracy of the Systemic Anti-Cancer Therapy dataset as a resource for rapid analysis of outcomes for patients, in this example, receiving Cancer Drug Fund funded monoclonal antibodies to treat metastatic colorectal cancer. We concluded that the Systemic Anti-Cancer Therapy dataset is a potentially valuable resource for rapidly determining survival outcome for patients treated with chemotherapy.

Original languageEnglish
Pages (from-to)e134-e136
JournalClinical Oncology
Volume29
Issue number7
DOIs
Publication statusPublished - Jul 2017

Bibliographical note

Publisher Copyright:
© 2017

Keywords

  • CDF
  • Cancer Drug Fund
  • SACT
  • Systemic Anti-Cancer Therapy dataset
  • cetuximab
  • colorectal

Fingerprint

Dive into the research topics of 'Rapid Analysis of Outcomes Using the Systemic Anti-Cancer Therapy (SACT) Dataset'. Together they form a unique fingerprint.

Cite this